Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
Urologic Oncology
|
July 22, 2014
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort
Laura-Maria Krabbe, Robert S Svatek, Shahrokh F Shariat, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 16, 2017
Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours
Matthew Truong, Lorraine Liang, Janet Kukreja, et al.
Urologic Oncology
|
May 5, 2010
BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress
Victoria L Robinson, Michael Porter, Edward Messing, et al.
Clinical Genitourinary Cancer
|
February 23, 2020
The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?
Emily Lemke, Deepak Sahasrabudhe, Elizabeth Guancial, et al.
BJU International
|
September 29, 2012
Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies
Emil Scosyrev, Scott Tobis, Heather Donsky, et al.
Female Pelvic Medicine & Reconstructive Surgery
|
July 30, 2019
Pelvic Floor Organ Prolapse After Radical Cystectomy in Patients With Uroepithelial Carcinoma
Lioudmila Lipetskaia, Toy Gee Lee, Dongmei Li, et al.
Frontiers in Immunology
|
April 29, 2026
Bacillus Calmette-Guérin immunotherapy-induced extracellular vesicles promote antitumor immunity in bladder cancer
Carlos J Ortiz-Bonilla, Ryan D Molony, Hiroshi Miyamoto, et al.
Urology Practice
|
August 3, 2023
Overall Survival after Partial Versus Radical Nephrectomy for a Small Renal Mass: Systematic Review of Observational Studies
Emil Scosyrev, Kevin Wu, Helen R Levey, et al.
JAMA
|
January 19, 2006
Surveillance for recurrent bladder cancer using a point-of-care proteomic assay
H Barton Grossman, Mark Soloway, Edward Messing, et al.
JAMA
|
February 17, 2005
Detection of bladder cancer using a point-of-care proteomic assay
H Barton Grossman, Edward Messing, Mark Soloway, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
Urologic Oncology
|
July 22, 2014
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort
Laura-Maria Krabbe, Robert S Svatek, Shahrokh F Shariat, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 16, 2017
Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours
Matthew Truong, Lorraine Liang, Janet Kukreja, et al.
Urologic Oncology
|
May 5, 2010
BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress
Victoria L Robinson, Michael Porter, Edward Messing, et al.
Clinical Genitourinary Cancer
|
February 23, 2020
The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?
Emily Lemke, Deepak Sahasrabudhe, Elizabeth Guancial, et al.
BJU International
|
September 29, 2012
Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies
Emil Scosyrev, Scott Tobis, Heather Donsky, et al.
Female Pelvic Medicine & Reconstructive Surgery
|
July 30, 2019
Pelvic Floor Organ Prolapse After Radical Cystectomy in Patients With Uroepithelial Carcinoma
Lioudmila Lipetskaia, Toy Gee Lee, Dongmei Li, et al.
Frontiers in Immunology
|
April 29, 2026
Bacillus Calmette-Guérin immunotherapy-induced extracellular vesicles promote antitumor immunity in bladder cancer
Carlos J Ortiz-Bonilla, Ryan D Molony, Hiroshi Miyamoto, et al.
Urology Practice
|
August 3, 2023
Overall Survival after Partial Versus Radical Nephrectomy for a Small Renal Mass: Systematic Review of Observational Studies
Emil Scosyrev, Kevin Wu, Helen R Levey, et al.
JAMA
|
January 19, 2006
Surveillance for recurrent bladder cancer using a point-of-care proteomic assay
H Barton Grossman, Mark Soloway, Edward Messing, et al.
JAMA
|
February 17, 2005
Detection of bladder cancer using a point-of-care proteomic assay
H Barton Grossman, Edward Messing, Mark Soloway, et al.
Page
of 8